INS and early-onset autosomal dominant Alzheimer disease: Type 2 Diabetes is a major risk factor for Alzheimer’s disease and dementia and the concept that Alzheimer’s is fundamentally a metabolic disease that results in progressive impairment in the brain’s capacity to utilize glucose and respond to insulin/insulin like growth factor stimulation has recently gained increasing support44, 45.